Username Password
S&P 500: 1,317.45 Change: +0.03%
Zacks_Analysts
At least 5 active picks are required to calculate a P&P score.

Zacks_Analysts' Blog : Zacks Updates from AHA - Analyst Blog

Date November 19, 2010    Comments Comments (0)    Rate this post Recommend This Post (39)   
Bookmark and Share
Abuse this post  Report Abuse
Please report this as abuse only if you believe it violates People And Picks  Terms of Use
You must log in to send an abuse report.
Share ThisShare This


by Zacks Small-Cap Research



Earlier this week, Zacks Small-Cap Research biotechnology analysts, Jason Napodano, CFA, was in attendance at the American Heart Association (AHA) meeting held in Chicago, Il.  Napodano has updated his research reports on Aastrom Biosciences (ASTM), Cytori Therapeutics (CYTX), and Nile Therapeutics (NLTX) following key data presentations on these stocks over the past week.



For a copy of the Zacks Small-Cap Research report on Aastrom Biosciences (ASTM), Cytori Therapeutics (CYTX), and / or Nile Therapeutics (NLTX), please email SCR @ Zacks.com with the ticker symbols ASTM, CYTX, and / or NLTX in the subject line.



Read the full analyst report on "CYTX"
Read the full analyst report on "ASTM"
Read the full analyst report on "NLTX"
Zacks Investment Research
Tags : CFA   AHA   ASTM   CYTX   NLTX   SCR  

Want to comment on this post? Sign up now. It's FREE!
Already registered? Log In.
Sponsored Links